Wadhane Jitendra
- SEC CIK
- 0001941706
No open-market purchases or sales filed in the past year.
Current role at each company
- PYXS Pyxis Oncology, Inc.Prin Fin & Acct Officeras of Mar 25, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wadhane Jitendra as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2023 (view filing) | Sep 27 | Same day | Wadhane JitendraChief Accounting Officer | PPurchase | +2.50K | $1.87 | +$4.67K | +1.1%226.9K after | |
| Sep 25, 2023 (view filing) | Sep 25 | Same day | Wadhane JitendraChief Accounting Officer | PPurchase | +5.00K | $1.77 | +$8.85K | +2.3%224.4K after | |
| Sep 22, 2023 (view filing) | Sep 22 | Same day | Wadhane JitendraChief Accounting Officer | PPurchase | +2.50K | $1.74 | +$4.35K | +1.2%219.4K after |